Former director (through FY2025) · Vor Biopharma Inc. (VOR)

David Lubner director compensation at Vor Biopharma (FY2025): $35.3K

Fiscal year 2025 director compensation for David Lubner at Vor Biopharma Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get David Lubner’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track David Lubner and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Vor Biopharma Director Compensation Table · all 4 fiscal years held
In US dollars, as Vor Biopharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$31,107—$4,200—$35,307
FY2024$47,500$0$34,800$0$82,300
FY2023$47,500—$104,100—$151,600
FY2021$41,285—$304,200—$345,485

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vor Biopharma Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-181883, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vor Biopharma Inc. filed document, accession 0001193125-26-181883. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Vor Biopharma Board Governance Report

$35,307 David Lubner, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Vor Biopharma pays directors a $40,000 cash retainer and $350,000 in Options.

The rest of the Vor Biopharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alexander (Bo) CumboIndependent Director$121,365
Andrew LevinIndependent Director$31,881
Daniella BeckmanLead Independent Director$64,200
Erez KalirIndependent Director$123,033
Fouad NamouniIndependent Director$51,089
Jean-Paul KressChair of the Board—
Michel DetheuxIndependent Director$119,350
Wouter JoustraIndependent Director$31,881

The full Vor Biopharma compensation record

free company brief

This page is one director within Vor Biopharma's record. The company brief lists every named executive and director, each linking to their own page.

Order VOR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report